• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

备解素:一种参与炎症和疾病的多功能分子。

Properdin: A multifaceted molecule involved in inflammation and diseases.

机构信息

Department of Medical Microbiology and Immunology, University of Toledo College of Medicine and Life Sciences, Toledo, OH, United States.

Department of Biomedical Sciences, University of Oakland University School of Medicine, Rochester, MI, United States.

出版信息

Mol Immunol. 2018 Oct;102:58-72. doi: 10.1016/j.molimm.2018.05.018. Epub 2018 Jun 27.

DOI:10.1016/j.molimm.2018.05.018
PMID:29954621
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7375857/
Abstract

Properdin, the widely known positive regulator of the alternative pathway (AP), has undergone significant investigation over the last decade to define its function in inflammation and disease, including its role in arthritis, asthma, and kidney and cardiovascular diseases. Properdin is a glycoprotein found in plasma that is mainly produced by leukocytes and can positively regulate AP activity by stabilizing C3 and C5 convertases and initiating the AP. Promotion of complement activity by properdin results in changes in the cellular microenvironment that contribute to innate and adaptive immune responses, including pro-inflammatory cytokine production, immune cell infiltration, antigen presenting cell maturation, and tissue damage. The use of properdin-deficient mouse models and neutralizing antibodies has contributed to the understanding of the mechanisms by which properdin contributes to promoting or preventing disease pathology. This review mainly focusses on the multifaceted roles of properdin in inflammation and diseases, and how understanding these roles is contributing to the development of new disease therapies.

摘要

备解素,即众所周知的补体旁路途径(AP)的正向调节剂,在过去十年中经历了大量的研究,以明确其在炎症和疾病中的功能,包括其在关节炎、哮喘以及肾脏和心血管疾病中的作用。备解素是一种在血浆中发现的糖蛋白,主要由白细胞产生,可以通过稳定 C3 和 C5 转化酶和启动 AP 来正向调节 AP 活性。备解素促进补体活性会导致细胞微环境发生变化,从而促进先天和适应性免疫反应,包括促炎细胞因子的产生、免疫细胞浸润、抗原呈递细胞成熟和组织损伤。使用备解素缺陷型小鼠模型和中和抗体有助于理解备解素促进或预防疾病病理的机制。这篇综述主要关注备解素在炎症和疾病中的多方面作用,以及了解这些作用如何有助于开发新的疾病治疗方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9bd0/7375857/6e029365fd1c/nihms-1598111-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9bd0/7375857/875ab19c8e03/nihms-1598111-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9bd0/7375857/f10f43c3346e/nihms-1598111-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9bd0/7375857/cd5b13feaccb/nihms-1598111-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9bd0/7375857/6e029365fd1c/nihms-1598111-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9bd0/7375857/875ab19c8e03/nihms-1598111-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9bd0/7375857/f10f43c3346e/nihms-1598111-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9bd0/7375857/cd5b13feaccb/nihms-1598111-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9bd0/7375857/6e029365fd1c/nihms-1598111-f0004.jpg

相似文献

1
Properdin: A multifaceted molecule involved in inflammation and diseases.备解素:一种参与炎症和疾病的多功能分子。
Mol Immunol. 2018 Oct;102:58-72. doi: 10.1016/j.molimm.2018.05.018. Epub 2018 Jun 27.
2
The Role of Properdin in C5 Convertase Activity and C5b-9 Formation in the Complement Alternative Pathway.补体替代途径中备解素在 C5 转化酶活性和 C5b-9 形成中的作用。
J Immunol. 2021 Nov 15;207(10):2465-2472. doi: 10.4049/jimmunol.2100238. Epub 2021 Oct 11.
3
Genetic and therapeutic targeting of properdin in mice prevents complement-mediated tissue injury.在小鼠中遗传和治疗靶向备解素可预防补体介导的组织损伤。
J Clin Invest. 2010 Oct;120(10):3545-54. doi: 10.1172/jci41782.
4
Linkage specificity and role of properdin in activation of the alternative complement pathway by fungal glycans.甘露聚糖特异性补体激活途径及其在真菌糖激活替代途径中的作用。
mBio. 2011 Aug 30;2(5). doi: 10.1128/mBio.00178-11. Print 2011.
5
Properdin and complement activation: a fresh perspective.备解素与补体激活:一个新视角。
Curr Drug Targets. 2008 Feb;9(2):158-64. doi: 10.2174/138945008783502458.
6
Recruitment of properdin by bi-specific nanobodies activates the alternative pathway of complement.双特异性纳米抗体募集备解素激活补体的替代途径。
Mol Immunol. 2020 Aug;124:200-210. doi: 10.1016/j.molimm.2020.06.005. Epub 2020 Jun 26.
7
Identification of a novel mode of complement activation on stimulated platelets mediated by properdin and C3(H2O).鉴定补体在受刺激血小板上通过备解素和 C3(H2O)介导的新型激活方式。
J Immunol. 2013 Jun 15;190(12):6457-67. doi: 10.4049/jimmunol.1300610. Epub 2013 May 15.
8
Initial properdin binding contributes to alternative pathway activation at the surface of viable and necrotic cells.初始备解素结合有助于替代途径在活细胞和坏死细胞表面的激活。
Eur J Immunol. 2022 Apr;52(4):597-608. doi: 10.1002/eji.202149259. Epub 2022 Feb 17.
9
Properdin homeostasis requires turnover of the alternative complement pathway.补体固有途径的稳态需要替代途径的转换。
Proc Natl Acad Sci U S A. 2010 Nov 9;107(45):19444-8. doi: 10.1073/pnas.1006608107. Epub 2010 Oct 25.
10
Serum properdin consumption as a biomarker of C5 convertase dysregulation in C3 glomerulopathy.血清备解素消耗作为C3肾小球病中C5转化酶失调的生物标志物。
Clin Exp Immunol. 2016 Apr;184(1):118-25. doi: 10.1111/cei.12754. Epub 2016 Jan 22.

引用本文的文献

1
Differential modulation of SARS-CoV-2 infection by complement factor H and properdin.补体因子H和备解素对严重急性呼吸综合征冠状病毒2感染的差异调节作用
Front Immunol. 2025 Aug 15;16:1620229. doi: 10.3389/fimmu.2025.1620229. eCollection 2025.
2
Imidazole propionate is a driver and therapeutic target in atherosclerosis.咪唑丙酸是动脉粥样硬化的驱动因素和治疗靶点。
Nature. 2025 Jul 16. doi: 10.1038/s41586-025-09263-w.
3
Sialylation as a checkpoint for inflammatory and complement-related retinal diseases.唾液酸化作为炎症和补体相关视网膜疾病的一个检查点。

本文引用的文献

1
Human Properdin Modulates Macrophage: BCG Interaction Thrombospondin Repeats 4 and 5.人补体因子 P 调节巨噬细胞:卡介苗相互作用 血栓反应蛋白重复 4 和 5。
Front Immunol. 2018 May 8;9:533. doi: 10.3389/fimmu.2018.00533. eCollection 2018.
2
Human Properdin Opsonizes Nanoparticles and Triggers a Potent Pro-inflammatory Response by Macrophages without Involving Complement Activation.人普里登蛋白对纳米颗粒调理,并通过巨噬细胞引发强烈的促炎反应,而不涉及补体激活。
Front Immunol. 2018 Feb 12;9:131. doi: 10.3389/fimmu.2018.00131. eCollection 2018.
3
Extracellular vesicles from KSHV-infected endothelial cells activate the complement system.
Front Cell Neurosci. 2025 Jun 27;19:1623755. doi: 10.3389/fncel.2025.1623755. eCollection 2025.
4
MASP1 in stomach adenocarcinoma: linking diagnosis, prognosis, and tumor immunity.胃腺癌中的MASP1:连接诊断、预后和肿瘤免疫
Discov Oncol. 2025 Jun 13;16(1):1085. doi: 10.1007/s12672-025-02900-w.
5
Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of ALXN1820 (Tarperprumig) in Healthy Adults: Results of a Phase I Study.ALXN1820(Tarperprumig)在健康成年人中的安全性、耐受性、药代动力学、药效学及免疫原性:一项I期研究的结果
Clin Transl Sci. 2025 Apr;18(4):e70190. doi: 10.1111/cts.70190.
6
Seventy Years Later: Systemic and Local Properdin in Atherosclerosis.七十年后:动脉粥样硬化中的系统性和局部备解素
J Am Heart Assoc. 2025 Feb 4;14(3):e040305. doi: 10.1161/JAHA.124.040305. Epub 2025 Jan 28.
7
Alternative Complement Pathway in Carotid Atherosclerosis: Low Plasma Properdin Levels Associate With Long-Term Cardiovascular Mortality.颈动脉粥样硬化中的替代补体途径:血浆备解素水平低与长期心血管死亡率相关。
J Am Heart Assoc. 2025 Feb 4;14(3):e038316. doi: 10.1161/JAHA.124.038316. Epub 2025 Jan 27.
8
Acinetobacter baumannii Clinical Isolates Resist Complement-Mediated Lysis by Inhibiting the Complement Cascade and Improperly Depositing MAC.鲍曼不动杆菌临床分离株通过抑制补体级联反应和错误沉积膜攻击复合物来抵抗补体介导的溶解。
J Innate Immun. 2025;17(1):112-125. doi: 10.1159/000543664. Epub 2025 Jan 22.
9
The Inhibitory Effects of a Factor B-Binding DNA Aptamer Family Supersede the Gain of Function of Factor B Variants Associated with Atypical Hemolytic Uremic Syndrome.Factor B 结合 DNA 适体家族的抑制作用超过与非典型溶血尿毒症综合征相关的因子 B 变体的功能获得。
J Immunol. 2024 Dec 1;213(11):1691-1702. doi: 10.4049/jimmunol.2400420.
10
Role of the complement system in kidney cell death induced by Loxosceles venom Sphingomyelinases D.补体系统在美洲大蠊毒液神经鞘磷脂酶 D 诱导的肾细胞死亡中的作用
Arch Toxicol. 2024 May;98(5):1561-1572. doi: 10.1007/s00204-024-03711-8. Epub 2024 Mar 18.
来自卡波西肉瘤相关疱疹病毒感染的内皮细胞的细胞外囊泡激活补体系统。
Oncotarget. 2017 Oct 9;8(59):99841-99860. doi: 10.18632/oncotarget.21668. eCollection 2017 Nov 21.
4
Factor H C-Terminal Domains Are Critical for Regulation of Platelet/Granulocyte Aggregate Formation.补体因子H的C末端结构域对血小板/粒细胞聚集体形成的调节至关重要。
Front Immunol. 2017 Nov 23;8:1586. doi: 10.3389/fimmu.2017.01586. eCollection 2017.
5
The renaissance of complement therapeutics.补体疗法的复兴。
Nat Rev Nephrol. 2018 Jan;14(1):26-47. doi: 10.1038/nrneph.2017.156. Epub 2017 Dec 4.
6
Complement anaphylatoxins C3a and C5a: Emerging roles in cancer progression and treatment.补体过敏毒素 C3a 和 C5a:在癌症进展和治疗中的新作用。
Semin Cell Dev Biol. 2019 Jan;85:153-163. doi: 10.1016/j.semcdb.2017.11.023. Epub 2017 Nov 23.
7
Inhibition of the complement system by saliva of Anopheles (Nyssorhynchus) aquasalis.按蚊(Nyssorhynchus)唾液对补体系统的抑制作用。
Insect Biochem Mol Biol. 2018 Jan;92:12-20. doi: 10.1016/j.ibmb.2017.11.004. Epub 2017 Nov 8.
8
Complement genomics and antibody-mediated rejection in heart recipients.补体基因组学与心脏移植受者的抗体介导排斥反应。
J Heart Lung Transplant. 2018 Apr;37(4):439-440. doi: 10.1016/j.healun.2017.08.008. Epub 2017 Aug 19.
9
Polymorphisms in genes related to the complement system and antibody-mediated cardiac allograft rejection.补体系统相关基因和抗体介导的心脏同种异体移植排斥反应的多态性。
J Heart Lung Transplant. 2018 Apr;37(4):477-485. doi: 10.1016/j.healun.2017.07.006. Epub 2017 Jul 15.
10
Complement factor P is a ligand for the natural killer cell-activating receptor NKp46.补体因子P是自然杀伤细胞激活受体NKp46的一种配体。
Sci Immunol. 2017 Apr 28;2(10). doi: 10.1126/sciimmunol.aam9628.